Hall Capital Management’s Pfizer PFE Stock Holding History

Hall Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,618	Closed	-$203K	–	113
2026 Q1	$203K	Buy	+7,618	New	+$203K	0.07%	107
2025 Q4	–	Sell	-8,318	Closed	-$212K	–	100
2025 Q3	$212K	Sell	8,318 -61	-0.7%	-$1.51K	0.08%	94
2025 Q2	$203K	Sell	8,379 -15	-0.2%	-$350	0.09%	94
2025 Q1	$213K	Sell	8,394 -9,845	-54%	-$258K	0.1%	90
2024 Q4	$484K	Buy	+18,239	New	+$495K	0.23%	61
2024 Q2	$571K	Sell	20,393 -585	-3%	-$16.1K	0.27%	60
2024 Q1	$582K	Sell	20,978 -8,984	-30%	-$249K	0.29%	56
2023 Q4	$863K	Sell	29,962 -5,856	-16%	-$177K	0.51%	44
2023 Q3	$1.19M	Sell	35,818 -6,987	-16%	-$247K	0.76%	41
2023 Q2	$1.57M	Sell	42,805 -5,063	-11%	-$197K	0.89%	39
2023 Q1	$1.95M	Sell	47,868 -19,345	-29%	-$836K	1.16%	33
2022 Q4	$3.44M	Sell	67,213 -1,653	-2%	-$79.3K	2.07%	17
2022 Q3	$3.01M	Buy	68,866 +2,926	+4%	+$142K	2.01%	16
2022 Q2	$3.46M	Buy	65,940 +1,803	+3%	+$91.9K	2.28%	14
2022 Q1	$3.32M	Buy	64,137 +324	+0.5%	+$16.8K	1.94%	17
2021 Q4	$3.77M	Buy	63,813 +7,484	+13%	+$371K	2.13%	17
2021 Q3	$2.42M	Sell	56,329 -15	-0%	-$665	1.55%	25
2021 Q2	$2.21M	Buy	+56,344	New	+$2.19M	1.42%	29
2020 Q4	$2.02M	Sell	54,858 -2,678	-5%	-$98.2K	1.46%	27
2020 Q3	$2M	Buy	57,536 +1,516	+3%	+$53.2K	1.59%	24
2020 Q2	$1.74M	Buy	56,020 +445	+0.8%	+$15.1K	1.46%	25
2020 Q1	$1.72M	Sell	55,575 -2,957	-5%	-$101K	1.76%	21
2019 Q4	$2.18M	Sell	58,532 -1,518	-3%	-$54.1K	1.77%	21
2019 Q3	$2.05M	Sell	60,050 -1,037	-2%	-$37.7K	1.78%	20
2019 Q2	$2.51M	Sell	61,087 -564	-0.9%	-$22.4K	2.14%	13
2019 Q1	$2.48M	Buy	61,651 +1,381	+2%	+$55.3K	2.16%	13
2018 Q4	$2.5M	Buy	60,270 +315	+0.5%	+$13.1K	2.48%	11
2018 Q3	$2.51M	Buy	59,955 +527	+0.9%	+$20.3K	2.17%	13
2018 Q2	$2.05M	Buy	59,428 +248	+0.4%	+$8.47K	1.93%	16
2018 Q1	$1.99M	Sell	59,180 -2,424	-4%	-$83.3K	1.91%	16
2017 Q4	$2.12M	Sell	61,604 -975	-2%	-$33.2K	1.85%	18
2017 Q3	$2.12M	Sell	62,579 -1,028	-2%	-$33K	1.95%	18
2017 Q2	$2.03M	Sell	63,607 -437	-0.7%	-$13.8K	1.91%	20
2017 Q1	$2.08M	Buy	64,044 +1,344	+2%	+$42.4K	1.97%	17
2016 Q4	$1.93M	Buy	+62,700	New	+$1.91M	1.88%	20
2015 Q3	$1.66M	Buy	55,759 +569	+1%	+$18.2K	1.98%	17
2015 Q2	$1.75M	Buy	55,190 +952	+2%	+$31K	1.99%	18
2015 Q1	$1.79M	Buy	54,238 +30	+0.1%	+$954	1.85%	20
2014 Q4	$1.6M	Buy	+54,208	New	+$1.55M	1.65%	26

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hall Capital Management's PFE Position: Q2 2026 in Review

Hall Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,618 shares — an estimated $203K sold.

Hall Capital Management first reported a position in PFE in Q4 2014 and held it in 39 quarters. The position peaked at $3.77M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Hall Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Hall Capital Management sold 7,618 Pfizer shares in Q2 2026, an estimated $203K.
Hall Capital Management first reported a position in Pfizer in Q4 2014 and held it in 39 quarters.
Hall Capital Management's Pfizer position peaked at $3.77M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hall Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.